Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice

[1]  Wei Liu,et al.  Sample preparation method for isolation of single‐cell types from mouse liver for proteomic studies , 2011, Proteomics.

[2]  V. Julia,et al.  NKT cells are required to induce high IL‐33 expression in hepatocytes during ConA‐induced acute hepatitis , 2011, European journal of immunology.

[3]  R. Le Goffic,et al.  Infection with influenza virus induces IL-33 in murine lungs. , 2011, American journal of respiratory cell and molecular biology.

[4]  P. Xiong,et al.  High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice , 2010, Journal of Molecular Medicine.

[5]  P. Preshaw,et al.  Expression and regulation of interleukin‐33 in human monocytes , 2010, Immunology.

[6]  Q. Gong,et al.  IL-33 Prolongs Murine Cardiac Allograft Survival Through Induction of TH2-Type Immune Deviation , 2010, Transplantation.

[7]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[8]  Qutayba Hamid,et al.  Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1 , 2009, The Journal of Immunology.

[9]  F. Liew,et al.  The cytokine interleukin-33 mediates anaphylactic shock , 2009, Proceedings of the National Academy of Sciences.

[10]  H. Gascan,et al.  Interleukin-33 overexpression is associated with liver fibrosis in mice and humans , 2009, Journal of cellular and molecular medicine.

[11]  J. Pollheimer,et al.  Interleukin-33 - cytokine of dual function or novel alarmin? , 2009, Trends in immunology.

[12]  P. Gourdy,et al.  The pro‐Th2 cytokine IL‐33 directly interacts with invariant NKT and NK cells to induce IFN‐γ production , 2009, European journal of immunology.

[13]  Lan Wu,et al.  Natural killer T cells and autoimmune disease. , 2009, Current molecular medicine.

[14]  S. Shono,et al.  Superoxide produced by Kupffer cells is an essential effector in concanavalin A–induced hepatitis in mice , 2008, Hepatology.

[15]  J. Girard,et al.  The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.

[16]  I. McInnes,et al.  IL-33 exacerbates antigen-induced arthritis by activating mast cells , 2008, Proceedings of the National Academy of Sciences.

[17]  C. Gabay,et al.  IL‐1, IL‐18, and IL‐33 families of cytokines , 2008, Immunological reviews.

[18]  A. Yoshimura,et al.  Suppressor of cytokine signaling 1 protects mice against concanavalin A–induced hepatitis by inhibiting apoptosis , 2008, Hepatology.

[19]  M. Hayakawa,et al.  Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation* , 2007, Journal of Biological Chemistry.

[20]  R. Kastelein,et al.  IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex , 2007, The Journal of Immunology.

[21]  R. Sun,et al.  The roles of innate immune cells in liver injury and regeneration. , 2007, Cellular & molecular immunology.

[22]  P. Xiong,et al.  Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. , 2006, Biochemical and biophysical research communications.

[23]  R. Sun,et al.  Interleukin‐15 prevents concanavalin A‐induced liver injury in mice via NKT cell‐dependent mechanism , 2006, Hepatology.

[24]  R. Sun,et al.  Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism. , 2006, Journal of hepatology.

[25]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[26]  A. August,et al.  Natural killer T cells: rapid responders controlling immunity and disease. , 2005, The international journal of biochemistry & cell biology.

[27]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[28]  R. Sun,et al.  Crucial Role of IL-4/STAT6 in T Cell-Mediated Hepatitis: Up-Regulating Eotaxins and IL-5 and Recruiting Leukocytes , 2003, The Journal of Immunology.

[29]  D. Abramowicz,et al.  Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. , 2002, Gastroenterology.

[30]  L. Kaer,et al.  Critical contribution of liver natural killer T cells to a murine model of hepatitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Matsushima,et al.  Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. , 2000, Cytokine.

[32]  M. Taniguchi,et al.  Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis , 2000, The Journal of experimental medicine.

[33]  A. Wendel,et al.  Concanavalin A hepatotoxicity in mice: Tumor necrosis factor–mediated organ failure independent of caspase‐3–like protease activation , 1999, Hepatology.

[34]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[35]  S. Küsters,et al.  Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. , 1996, Gastroenterology.

[36]  E. O’Neill,et al.  T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6 , 1994, The Journal of experimental medicine.

[37]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[38]  N. Arsenijević,et al.  Protective role of IL-33/ST2 axis in Con A-induced hepatitis. , 2012, Journal of hepatology.

[39]  Q. Gong,et al.  High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response , 2011, Laboratory Investigation.

[40]  L. Van Kaer.  NKT cells: T lymphocytes with innate effector functions. , 2007, Current opinion in immunology.